Vicarious Surgical (RBOT) Cash & Current Investments (2020 - 2025)

Vicarious Surgical's (RBOT) quarterly Cash & Current Investments came in at $9.8 million in Q4 2025, down 80.06% year-on-year from $49.1 million in Q4 2024, and down 58.62% on a QoQ basis from $23.7 million in Q3 2025.

Vicarious Surgical (RBOT) Cash & Current Investments (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has 6 years of Cash & Current Investments data on file, last reported at $9.8 million in Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 80.06% year-over-year to $9.8 million in Q4 2025; TTM through Dec 2025 was $9.8 million, a 80.06% decrease from a year earlier, with the FY2025 full-year figure at $9.8 million, down 80.06% from the prior year.
  • Cash & Current Investments for Q4 2025 stood at $9.8 million, down from $23.7 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for RBOT reached as high as $185.0 million in Q3 2021 and fell as low as $1.0 million in Q1 2021.
  • Historically, Cash & Current Investments has averaged $87.0 million across 5 years, with a median of $72.7 million in 2024.
  • Across the five-year window, Cash & Current Investments soared 15173.98% in 2022 and slumped 80.06% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $173.5 million in 2021, then sank by 33.02% to $116.2 million in 2022, then grew by 5.16% to $122.2 million in 2023, then tumbled by 59.82% to $49.1 million in 2024, then slumped by 80.06% to $9.8 million in 2025.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $9.8 million in Q4 2025, $23.7 million in Q3 2025, and $24.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 183.47 Bn 176.17 Bn 6.27 Bn 7.30 Bn
2 Stryker 128.89 Bn 126.01 Bn 3.81 Bn 2.88 Bn
3 Medtronic 108.71 Bn 99.49 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 68.50 Bn 67.05 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 48.59 Bn 44.92 Bn 1.29 Bn 3.67 Bn
6 Dexcom 28.40 Bn 27.29 Bn 750.30 Mn 1.12 Bn
7 GE HealthCare Technologies 28.34 Bn 26.06 Bn 1.98 Bn 2.29 Bn
8 Smith & Nephew 26.93 Bn 26.35 Bn - 577.00 Mn
9 Koninklijke Philips 25.50 Bn 22.37 Bn 2.07 Bn 3.12 Bn
10 Vicarious Surgical 625,212.51 -9.17 Mn - 9.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 9.79 Mn
Sep 30, 2025 23.66 Mn
Jun 30, 2025 23.96 Mn
Mar 31, 2025 72.13 Mn
Dec 31, 2024 49.10 Mn
Sep 30, 2024 60.86 Mn
Jun 30, 2024 73.23 Mn
Mar 31, 2024 123.64 Mn
Dec 31, 2023 122.20 Mn
Sep 30, 2023 169.30 Mn
Jun 30, 2023 50.06 Mn
Mar 31, 2023 54.18 Mn
Dec 31, 2022 116.21 Mn
Sep 30, 2022 126.80 Mn
Jun 30, 2022 141.32 Mn
Mar 31, 2022 157.01 Mn
Dec 31, 2021 173.51 Mn
Sep 30, 2021 185.05 Mn
Jun 30, 2021 7.71 Mn
Mar 31, 2021 1.03 Mn